CGOCX | VSGIX | CGOCX / VSGIX | |
Total Expense Ratio | 1.99 | 0.06 | 3,317% |
Annual Report Gross Expense Ratio | 2.00 | 0.06 | 3,333% |
Fund Existence | 20 years | 25 years | - |
Gain YTD | -4.038 | -4.502 | 90% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.23B | 35B | 6% |
Annual Yield % from dividends | 0.00 | 0.58 | - |
Returns for 1 year | 8.23 | 7.16 | 115% |
Returns for 3 years | 55.88 | 38.64 | 145% |
Returns for 5 years | 8.51 | 40.60 | 21% |
Returns for 10 years | -33.45 | 101.47 | -33% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FSMEX | 58.64 | -0.47 | -0.80% |
Fidelity Select Medical Tech and Devcs | |||
JGSRX | 12.73 | -0.14 | -1.09% |
JHancock Global Shareholder Yield R2 | |||
PGICX | 17.94 | -0.20 | -1.10% |
Virtus KAR Equity Income C | |||
WVMRX | 11.15 | -0.16 | -1.41% |
William Blair Mid Cap Value R6 | |||
MRSPX | 14.82 | -0.24 | -1.59% |
BlackRock Advantage SMID Cap R |